Rumor Identification: It is inconclusive whether raltegravir is effective against the new coronavirus, which has yet to be verified. Rumor Analysis: 1. A paper published in the New England Journal of Medicine on January 31, 2020, detailed the first case of a cure for novel coronavirus pneumonia in the United States with the use of raltegravir. However, it is impossible to tell from just one case whether the patient’s symptomatic improvement was related to the use of raltegravir, and acute viral infections are usually self-limiting. Ridecivir, a broad-spectrum antiviral drug, has not yet received marketing approval in any country worldwide due to its unsatisfactory results in phase III clinics for Ebola virus suppression. 2. Therefore, whether raltegravir is a “miracle drug” or not, we need to wait for clinical study data to verify its inhibitory effect on the new coronavirus. Special Note: There is no specific drug for novel coronavirus pneumonia. For patients with confirmed infection, supportive and symptomatic treatment measures are mainly taken, such as maintaining the stability of the patient’s internal environment and giving oxygen monitoring. Antiviral drugs can be used alpha-interferon nebulized inhalation, or oral lopinavir or ritonavir, if necessary, can be combined with antibacterial drugs.